Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
1.405
-0.135 (-8.77%)
May 6, 2025, 11:52 AM EDT - Market open
Editas Medicine Market Cap
Editas Medicine has a market cap or net worth of $117.61 million as of May 6, 2025. Its market cap has decreased by -74.38% in one year.
Market Cap
117.61M
Enterprise Value
-116.01M
1-Year Change
-74.38%
Ranking
Category
Stock Price
$1.41
Market Cap Chart
Since February 3, 2016, Editas Medicine's market cap has decreased from $649.70M to $117.61M, a decrease of -81.90%. That is a compound annual growth rate of -16.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 2, 2025 | 136.10M | 29.87% |
| Dec 31, 2024 | 104.80M | -87.33% |
| Dec 29, 2023 | 827.40M | 35.66% |
| Dec 30, 2022 | 609.90M | -66.42% |
| Dec 31, 2021 | 1.82B | -58.45% |
| Dec 31, 2020 | 4.37B | 187.69% |
| Dec 31, 2019 | 1.52B | 39.66% |
| Dec 31, 2018 | 1.09B | -15.40% |
| Dec 29, 2017 | 1.29B | 122.48% |
| Dec 30, 2016 | 577.90M | -11.05% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 739.39B |
| Johnson & Johnson | 375.64B |
| UnitedHealth Group | 364.02B |
| AbbVie | 351.09B |
| Novo Nordisk | 307.48B |
| Abbott Laboratories | 231.09B |
| Novartis AG | 223.50B |
| AstraZeneca | 221.69B |